Use of Insulin Sensitizers in NASH

Mouen Khashab, Naga Chalasani

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

Original languageEnglish (US)
Pages (from-to)1067-1087
Number of pages21
JournalEndocrinology and metabolism clinics of North America
Issue number4
StatePublished - Dec 2007
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Use of Insulin Sensitizers in NASH'. Together they form a unique fingerprint.

Cite this